BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37872130)

  • 1. A systematic review of the use of the then-test for evaluating health-related quality of life in cancer patients.
    McCurdy-Franks E; McCarvell V; Finkelstein S; Milton L; Behroozian T; Simone CB; Chow E; Finkelstein J
    Ann Palliat Med; 2023 Nov; 12(6):1187-1197. PubMed ID: 37872130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.
    Ousmen A; Conroy T; Guillemin F; Velten M; Jolly D; Mercier M; Causeret S; Cuisenier J; Graesslin O; Hamidou Z; Bonnetain F; Anota A
    Health Qual Life Outcomes; 2016 Dec; 14(1):167. PubMed ID: 27914467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
    Gough N; Koffman J; Ross JR; Riley J; Judson I
    PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values.
    Amin S; Joo S; Nolte S; Yoo HK; Patel N; Byrnes HF; Costa-Cabral S; Johnson CD
    BMC Cancer; 2022 May; 22(1):563. PubMed ID: 35596182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
    Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
    Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life among Women Breast Cancer Patients in Eastern China.
    Chen Q; Li S; Wang M; Liu L; Chen G
    Biomed Res Int; 2018; 2018():1452635. PubMed ID: 30065931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly.
    Reimer T; Gerber B
    Drugs Aging; 2010 Oct; 27(10):791-800. PubMed ID: 20883059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Sibhat SG; Fenta TG; Sander B; Gebretekle GB
    Health Qual Life Outcomes; 2019 Nov; 17(1):165. PubMed ID: 31690327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
    Kretschmer A; Ploussard G; Heidegger I; Tsaur I; Borgmann H; Surcel C; Mathieu R; de Visschere P; Valerio M; van den Bergh RCN; Marra G; Thibault C; Ost P; Gandaglia G; Tilki D;
    Eur Urol Focus; 2021 Jul; 7(4):742-751. PubMed ID: 32089495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
    Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
    Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
    Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
    Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
    Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszweksi KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
    Ann Oncol; 2020 Feb; 31(2):283-288. PubMed ID: 31959345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.